Humanized (Hu) mouse models, featuring cell line-derived xenograft (CDX) or patient-derived xenograft (PDX) tumors, have been utilized to study the efficacy of PD-1/PD-L1 immune checkpoint inhibitors (ICIs) across various cancer types. The gene discussed is CD274; the disease is cancer.